| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | INSP | Common Stock | Sale | -$1.91M | -9.39K | -9.06% | $203.33 | 94.3K | Apr 1, 2024 | By Trust | F1, F2 |
| transaction | INSP | Common Stock | Sale | -$2.19M | -10.7K | -11.34% | $204.35 | 83.6K | Apr 1, 2024 | By Trust | F2, F3 |
| transaction | INSP | Common Stock | Sale | -$2.39M | -11.6K | -13.93% | $205.27 | 71.9K | Apr 1, 2024 | By Trust | F2, F4 |
| transaction | INSP | Common Stock | Sale | -$697K | -3.38K | -4.7% | $206.19 | 68.6K | Apr 1, 2024 | By Trust | F2, F5 |
| transaction | INSP | Common Stock | Sale | -$294K | -1.42K | -2.07% | $207.25 | 67.1K | Apr 1, 2024 | By Trust | F2, F6 |
| transaction | INSP | Common Stock | Sale | -$311K | -1.49K | -2.22% | $208.34 | 65.6K | Apr 1, 2024 | By Trust | F2, F7 |
| transaction | INSP | Common Stock | Sale | -$274K | -1.31K | -2% | $209.46 | 64.3K | Apr 1, 2024 | By Trust | F2, F8 |
| transaction | INSP | Common Stock | Sale | -$48.9K | -232 | -0.36% | $210.99 | 64.1K | Apr 1, 2024 | By Trust | F2, F9 |
| transaction | INSP | Common Stock | Sale | -$93.8K | -440 | -0.69% | $213.26 | 63.7K | Apr 1, 2024 | By Trust | F2, F10 |
| holding | INSP | Common Stock | 9.69K | Apr 1, 2024 | Direct | ||||||
| holding | INSP | Common Stock | 118K | Apr 1, 2024 | By LLC | F11 | |||||
| holding | INSP | Common Stock | 116K | Apr 1, 2024 | By Family Trust | F12 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $202.785 to $203.78. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F2 | Securities held by the Timothy P. Herbert 2018 Family Continuation Trust c/u the Timothy P. Herbert 2018 Grantor Retained Annuity Trust. |
| F3 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $203.785 to $204.78. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F4 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $204.80 to $205.78. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F5 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $205.80 to $206.775. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F6 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $206.825 to $207.79. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F7 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $207.885 to $208.80. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F8 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $209.19 to $209.76. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F9 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $210.935 to $211.06. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F10 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $213.03 to $213.99. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F11 | Securities held by the TPH 2022 LLC. |
| F12 | Securities held by the Timothy P. Herbert 2013 Family Irrevocable GST Trust U/A/D November 27, 2013. |
This amendment is being filed to update the Form 4 filed on April 3, 2024 (the "Original Report") and reflect that the sales reported in the Original Report were made pursuant to a Rule 10b5-1 trading plan dated August 28, 2023.